Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
AI in Drug Discovery Market to reach USD 23.95 Billion by 2035 at 23.9% CAGR
EIN Presswire
AI in Drug Discovery Market to Surge from USD 3.48 Bn in 2026 to USD 23.95 Bn by 2035-By Escalating Drug Development Cost, Exponential Growth in Biomedical Data NY, CA, UNITED STATES, September 17, 2026 /EINPresswire.com/ -- The global AI in...
Zealand Pharma – Notification of holding of treasury shares
GlobeNewswire, Inc.
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology...
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
GlobeNewswire, Inc.
Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...
West Central Mental Health Expands Access to Mental Health Care with New Clinic in Springfield, MA
EIN Presswire
West Central Mental Health opens a new clinic in Springfield, expanding access to quality, compassionate mental health care for local families and individuals.
ZenaTech Completes Acquisition of ESM Software, Adding SaaS Revenue from Government, Healthcare and Financial Services
EIN Presswire
ZenaTech, Inc. (NASDAQ:ZENA) VANCOUVER, BRITISH COLUMBIA, CANADA, August 25, 2026 /EINPresswire.com/ -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial...
Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
GlobeNewswire, Inc.
BOSTON, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that...
Massachusetts Cannabis Control Commission Releases Potency Audit Results
Massachusetts Cannabis Control Commission
The audit tested the accuracy of THC potency on flower product labels WORCESTER—As part of its ongoing shelf audit program, the Massachusetts Cannabis Control Commission (Commission) recently completed a review of THC potency on cannabis flower...
Within Health Announces the 5th Annual Within Summit, Taking Place October 6–9, 2026
EIN Presswire
Virtual conference offers free attendance and CE-accredited tracks, bringing together clinicians, researchers, and advocates to advance eating disorder care.
Update - ZenaTech Completes Acquisition of ESM Software, Adding Strategy Execution and Compliance Software to its Enterprise SaaS Division, with Revenue from Government, Healthcare and Financial Services Customers
GlobeNewswire, Inc.
VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS),...
Father-Son Firm Raphel & Raphel Builds Trust in Massachusetts' Metro South On and Off the Case
EIN Presswire
From Mentoring to Delivering Six- and Seven-Figure Personal Injury Results, the West Bridgewater Firm Lives Up to Being "The Lawyers Our Community Chooses" WEST BRIDGEWATER, MA, UNITED STATES, August 25, 2026 /EINPresswire.com/ -- Raphel &...
ZenaTech Completes Acquisition of ESM Software, Adding Strategy Execution and Compliance Software to its Enterprise SaaS Division, with Revenue from Government, Healthcare and Financial Services Customers
GlobeNewswire, Inc.
VANCOUVER, British Columbia, Aug. 25, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS),...
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
GlobeNewswire, Inc.
DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care,...
Staritas Welcomes Robbie Abt as Chief Revenue Officer
EIN Presswire
BOSTON, PA, UNITED STATES, September 15, 2026 /EINPresswire.com/ -- Staritas announced today that Robbie Abt has joined the company as Chief Revenue Officer (CRO), bringing more than 20 years of executive leadership experience in high-growth...
Starling Oncology to Participate in Wells Fargo Healthcare Conference
GlobeNewswire, Inc.
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ: STLN), (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief...
Qosina to Showcase Expanded Solutions and Regulatory Expertise at MEDevice Boston 2026
GlobeNewswire, Inc.
Ronkonkoma, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Qosina, a global supplier of single-use components for the medical device and life sciences industries, will exhibit at MEDevice Boston 2026, August 26–27. At Booth 614, attendees can connect with the...
Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Roblox Corporation (NYSE: RBLX); Symbotic Inc. (NASDAQ: SYM); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your…
GlobeNewswire, Inc.
PHILADELPHIA, Aug. 24, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY): Grabar Law Office is investigating claims on behalf of shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY). What is The Investigation About?
REEV’s Neuro-Integration Program Doubles in Four Months
EIN Presswire
Jefferson Moss-Magee Rehabilitation, Community Health System, and DHR Health join REEV’s NIP, extending the program's reach to the West Coast and South Texas.
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
GlobeNewswire, Inc.
COPENHAGEN, Denmark, Sept. 17, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced that the first patient has been enrolled in Part 2 of the Phase 1b/2a clinical trial of SNIPR001 (NCT06938867), the Company's lead CRISPR-armed phage therapeutic...
‘Boston Marketers Connect’ Approaches Capacity – Final Opportunity to Join an Exclusive Gathering of B2B Marketing & Revenue Leaders
GlobeNewswire, Inc.
AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Vereigen Media, a global leader in B2B demand generation and zero outsourcing data intelligence, today announced that registration for its upcoming premier networking event, ‘Boston Marketers...
Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer
GlobeNewswire, Inc.
Paris, France, New York, USA, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Dr Grasso brings more than 28 years of public company, capital markets, and investment banking management experience Continues Cyllene Tx’s strategic business and clinical...
Sign up for:
Massachusetts Healthcare Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.